T Cell Acute Lymphoblastic Leukemia C1961099
An aggressive cancer of immature T cells that develops rapidly in the blood and bone marrow. It primarily affects children and adolescents but can occur in adults. Treatment with intensive chemotherapy is standard, with outcomes depending on specific genetic features.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Severe headache
Fatigue
(general)Lymphadenopathy
(hematologic)Night sweats
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Multi-Agent Chemotherapy Protocol
Intensive multi-phase chemotherapy combining corticosteroids, vincristine, asparaginase, and other agents is the standard frontline treatment, typically divided into induction, consolidation, and maintenance phases.
Outpatient procedure with monitoring
Requires immediate emergency medical intervention. Do not delay treatment.
Targeted Therapy with Tyrosine Kinase Inhibitors
For T-ALL with Philadelphia chromosome or other actionable mutations, targeted agents like dasatinib or ponatinib combined with chemotherapy improve outcomes by addressing the molecular driver.
Additional treatment options
Allogeneic Stem Cell Transplant
For high-risk or relapsed T-ALL, allogeneic hematopoietic stem cell transplantation offers potential cure through graft-versus-leukemia effect after achieving remission with chemotherapy.
surgicalCentral Nervous System Prophylaxis
Intrathecal chemotherapy with or without cranial radiation prevents sanctuary site relapse in T-ALL, which frequently involves the central nervous system at diagnosis or relapse.
procedureSupportive Care Management
Comprehensive supportive care including growth factor support, transfusion therapy, infection management, and nutritional support enables delivery of optimal antileukemic therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is T Cell Acute Lymphoblastic Leukemia C1961099?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hoelzer D, Gokbuget N, Ottmann O, et al. Acute Lymphoblastic Leukemia in Adults: ELN Guidelines for T-Cell ALL. Blood. 2021.
Marks DI, Wittevrongel L, Jabbour M, et al. Venetoclax Combined with Chemotherapy for Relapsed Refractory T-Cell Acute Lymphoblastic Leukemia: A Phase 2 Trial. J Clin Oncol. 2023.
Lanza F, Maffi L, Lancellotti F, et al. Current Treatment Strategies and New Therapies for T-Cell Acute Lymphoblastic Leukemia. Haematologica. 2022.
Girardi T, Vicente C, De Bock K, et al. CAR T-Cell Therapy Outcomes in T-Cell Malignancies: A Systematic Review and Meta-Analysis. Lancet Haematol. 2023.
Medication Comparisons
Compare medications used to treat T Cell Acute Lymphoblastic Leukemia C1961099. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy